WGS241115P35000
- 0.05
- -0.40-88.89%
GeneDx Holdings Newsroom
GeneDx Holdings Corp. (WGS) Q3 2024 Earnings Call Transcript Summary
Wells Fargo Maintains GeneDx Holdings(WGS.US) With Hold Rating, Raises Target Price to $75
TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $75
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $95
12 Health Care Stocks Moving In Tuesday's Intraday Session
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday
GeneDx Holdings Corp. (WGS) Tops Q3 Earnings and Revenue Estimates
GeneDx Q3 Net Loss Narrows as Revenue Gains; 2024 Revenue Guidance Lifted -- Shares Rise Pre-Bell
10-Q: Q3 2024 Earnings Report
GeneDx GAAP EPS of -$0.31 Beats by $0.13, Revenue of $76.88M Beats by $11.89M
Express News | GeneDx Holdings Corp: Raising Guidance to Deliver Between $284M and $290M in FY 2024 Revenue
GeneDx Holdings 3Q Loss/Shr 31c >WGS
GeneDx Holdings 3Q Rev $76.9M >WGS
Express News | GeneDx Q3 Revenue USD 76.6 Million Vs. IBES Estimate USD 65 Million
Press Release: GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights
Here's the Major Earnings Before the Open Tomorrow
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $70
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $70
Earnings Preview: WGS to Report Financial Results Pre-market on October 29
$GeneDx Holdings(WGS.US)$ is scheduled to release its financial results pre-market on October 29 ET. Earnings PreviewAnalysts estimate $GeneDx Holdings(WGS.US)$ to post revenue of USD64.99M for 2024Q3
The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts